search
Back to results

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Primary Purpose

Heart Failure, Diastolic

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise training
Sponsored by
University of Texas Southwestern Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure, Diastolic focused on measuring Exercise, Hemodynamics,, Heart failure

Eligibility Criteria

60 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • signs and symptoms of heart failure
  • an ejection fraction > 0.50
  • objective evidence of diastolic dysfunction

Exclusion Criteria:

  • age < 60 years
  • BMI > 50 kg/m2
  • PDE5 inhibitor use
  • Severe valvular disease
  • Severe COPD
  • CKD 4 or higher
  • Contra-indication to MRI.

Sites / Locations

  • The Institute for Exercise and Environmental MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Central HFpEF whole body exercise

Central HFpEF isolated single leg exercise

Peripheral HFpEF whole body exercise

Peripheral HFpEF isolated single leg exercise

Arm Description

HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to whole body cycle training.

HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to isolated single leg training.

HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to whole body cycle training.

HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to isolated single leg training.

Outcomes

Primary Outcome Measures

Aerobic fitness
Change in peak VO2 after exercise training

Secondary Outcome Measures

Cardiopulmonary hemodynamics
Change in exercise pulmonary capillary wedge pressure
Sympathetic activity
Change in muscle sympathetic activity
Leg blood flow
Change in leg blood flow assessed by Doppler velocities in femoral artery
Cardiac fibrosis
Change in T1 mapping times by cardiac MRI

Full Information

First Posted
August 22, 2019
Last Updated
June 6, 2023
Sponsor
University of Texas Southwestern Medical Center
Collaborators
The University of Texas at Arlington
search

1. Study Identification

Unique Protocol Identification Number
NCT04068844
Brief Title
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
Official Title
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
July 1, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas Southwestern Medical Center
Collaborators
The University of Texas at Arlington

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.
Detailed Description
This will be a randomized, non-blinded prospective intervention testing the effects of two types of exercise training, whole body and isolated single leg, on HFpEF patients with either central or peripheral limitations to exercise training. Subjects will undergo baseline maximal exercise testing and invasive right heart catheterization to define exercise tolerance and pulmonary and cardiac pressures during exercise. Based on the results of baseline testing, subjects will be divided into either centrally limited, defined as excessive rise in pulmonary capillary wedge pressure more than 25 mmHg that decreases after administration of sub-lingual nitroglycerin resulting in improved exercise tolerance, or peripherally limited, defined as no improvement in exercise tolerance despite reduction in pulmonary capillary wedge pressure after sublingual nitroglycerin. After baseline testing, subjects will be randomized to either whole body cycle exercise supplemented with sublingual nitroglycerin to improve training responsiveness or isolated single leg exercise training for 4 months. After 4 months, subjects will repeat maximal exercise testing and invasive right heart catheterization to assess responses to 4 months of exercise training.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Diastolic
Keywords
Exercise, Hemodynamics,, Heart failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
HFpEF patients with either central or peripheral limitations to exercise will be randomly assigned to either whole body or isolated single leg exercise.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Central HFpEF whole body exercise
Arm Type
Experimental
Arm Description
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to whole body cycle training.
Arm Title
Central HFpEF isolated single leg exercise
Arm Type
Experimental
Arm Description
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to isolated single leg training.
Arm Title
Peripheral HFpEF whole body exercise
Arm Type
Experimental
Arm Description
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to whole body cycle training.
Arm Title
Peripheral HFpEF isolated single leg exercise
Arm Type
Experimental
Arm Description
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to isolated single leg training.
Intervention Type
Behavioral
Intervention Name(s)
Exercise training
Intervention Description
Exercise training, either whole body or isolated single leg
Primary Outcome Measure Information:
Title
Aerobic fitness
Description
Change in peak VO2 after exercise training
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Cardiopulmonary hemodynamics
Description
Change in exercise pulmonary capillary wedge pressure
Time Frame
4 months
Title
Sympathetic activity
Description
Change in muscle sympathetic activity
Time Frame
4 months
Title
Leg blood flow
Description
Change in leg blood flow assessed by Doppler velocities in femoral artery
Time Frame
4 months
Title
Cardiac fibrosis
Description
Change in T1 mapping times by cardiac MRI
Time Frame
4 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: signs and symptoms of heart failure an ejection fraction > 0.50 objective evidence of diastolic dysfunction Exclusion Criteria: age < 60 years BMI > 50 kg/m2 PDE5 inhibitor use Severe valvular disease Severe COPD CKD 4 or higher Contra-indication to MRI.
Facility Information:
Facility Name
The Institute for Exercise and Environmental Medicine
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary B Childers
Phone
214-345-6459
Email
MaryBChilders@texashealth.org
First Name & Middle Initial & Last Name & Degree
Benjamin D Levine, M.D.

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

We'll reach out to this number within 24 hrs